Wednesday, May 30, 2012

Highest Aspirations

Hello, A reminder for you and me to keep looking up when life seems to be keeping us down!
Thanks for visiting,
Janet :)

"Far away, there in the sunshine, are my highest aspirations. I may not reach them, but I can look up and see their beauty, believe in them, and try to follow where they lead"
Louisa May Alcott

Sunday, May 27, 2012

Meridian Tapping

Hello, I hope you are all enjoying your weekend. I was researching the internet for new advances in treatments for Mental Health as I usually do for this blog. I came across the Meridian Tapping Technique. I thought it would be a good follow up to my last post on Anxiety Attacks. This can be used for so many Mental Health issues, either on it's own or with other therapies. Some of you may have heard of it before, I personally never have, but if not you may want to check out this method. The basic principle is to release the negative energy that builds up in us, through past traumatic events, or general stressors in life. I am going to learn more about this and try it. I will share any new information I learn and my results with you, if any!
Thanks for visiting,
Janet :)

Points on the body to apply
the Tapping Technique

Meridian Tapping Techniques repair blockages or disturbances in the body's energy system created by negative emotions. A person chooses a specific emotion such as feeling anger, frustration, embarrassment, insult, or belittlement to focus on prior to the tapping session. During the tapping sequence the person focuses on the emotion to be reduced or cleared while also making positive statements to offset the negative emotions. The tapping of fingers tips on various points on the body release pent up energies

Meridian Tapping Founder:
George Goodheart, a chiropractic doctor, is noted for first discovering that tapping the meridians (acupuncture points) was beneficial in the treatment of physical issues. Tapping was done with the finger tips as an alternative to using acupuncture needles. Australian psychiatrist, John Diamond, implemented verbal affirmations to coincide with Goodheart's tapping sequences. A third doctor, psychologist Dr. Roger Callahan who developed TFT added a third component: "focusing" on a negative emotion to clear away

Benefits of MTT:
Stress Relief
Peace of Mind
Calms Anxiety
Pain Management
Helps Resolve Emotional Issues

Wednesday, May 23, 2012

Friends Are The Flowers

Hello, I hope you are all having a good week, a little poem for all of you my friends, to let you know that I am thinking of you!
Thanks for visiting,
Janet :)

Thursday, May 17, 2012

Dim All The Lights

Hello, I was sadden to hear the news about Donna Summer today. She is gone to soon, but what a legacy she has left behind. I never realized until today that she was from the Boston area, which makes me even a little more proud of her now, coming from where she did. I danced to all her hits in the 70's and 80's, sometimes by myself, sometimes out in the clubs with my girlfriends. I remember "Dim All The Lights" was a song that reminded me of a boy I had a big crush on for a long time! It's funny to me now looking back, I think she was pushing the envelope a bit before Madonna came along with "Love To Love You Baby". So kudos to her for being so brave. I'm grateful today that her voice and music will always be a part of many good memories in my life. May she rest in peace.
Thanks for visiting,
Janet :)


One of my favorites!

Disco queen Donna Summer has died, a family spokesperson told the Associated Press. She was 63.
Her family released a statement Thursday saying Summer had died and that they "are at peace celebrating her extraordinary life and her continued legacy."'

Summer had been living in Englewood, Fla., with her husband Bruce Sudano.

TMZ first reported the news, noting Summer had died in Florida on Thursday after a long battle with cancer. Insiders told TMZ she was recently working on music for a new album.

Known as the "Queen of Disco," Summer was born LaDonna Adrian Gaines in Boston, Mass., in 1948, as one of seven children. She was raised on Gospel music

The five-time Grammy winner rose to fame in the 1970s, scoring hits with "Last Dance," "Hot Stuff" and "Bad Girls." She co-wrote the single "Love to Love You Baby" in 1975, and went on to co-write several other hits, including "She Works Hard For Her Money."

"Love to Love You Baby" was her U.S. chart debut and the first of 19 No. 1 dance hits between 1975 and 2008 - second only to Madonna.

During the disco era, she burned up the charts: She was the only artist to have three consecutive double-LPs hit No. 1, "Live and More," "Bad Girls" and "On the Radio." She was also the first female artist with four No. 1 singles in a 13-month period, according to the Rock Hall of Fame, where she was a nominee this year.

Summer released a number of albums that have reached gold or platinum status, including the multiplatinum "Bad Girls" and "On the Radio, Volume I & II." Her No. 1 Billboard Hot 100 hits include "Hot Stuff" and "MacArthur Park."

Summer also appeared in the 1978 film, "Thank God It's Friday," which took home the best original song Oscar for "Last Dance."

The singer came to prominence just as disco was burgeoning, and came to define the era with a string of No. 1 hits and her beauty queen looks.

But unlike some other stars of disco who faded as the music became less popular, she was able to grow beyond it and later segued to a pop-rock sound. She had one of her biggest hits in the 1980s with "She Works Hard For The Money," which became another anthem, this time for women's rights.

Soon after, Summer became a born-again Christian and faced controversy when she was accused of making anti-gay comments in relation to the AIDS epidemic. Summer denied making the comments, but was the target of a boycott.

Still, even as disco went out of fashion, she remained a fixture in dance clubs, endlessly sampled and remixed into contemporary dance hits.

Summer's last album, "Crayons," came out in 2008. She also performed on "American Idol" that year with its top female contestants. In 2010, Summer appeared on "America's Got Talent."

Her sound was a mix of genres and helped her earn Grammy Awards in the dance, rock, R&B and inspirational categories.

Publicist Michael Levine, president of Levine Communications Office, represented Summer in 2002. He told, "She had more energy in her early '50s than most artists have in their '20s."

Levine also said Summer was very passionate about religion, noting how she used to hold a weekly bible study class at her home during that time.

Summer married Brooklyn Dreams vocalist Sudano in 1980. She is survived by her husband, three daughters and four grandchildren.

Monday, May 14, 2012

It Is Okay

Hello, These words from Kiran Shaikh are a good reminder for anyone who is going through a tough time. I know for sure now, having gone through my own difficult times, that the energy we waist into putting on a brave front, is energy we could have used to just feel, learn and grow.
Thanks for visiting,
Janet :)


Never apologise for what you feel .......
It is okay to be sensitive. It is okay to be "Emotional"
It is okay to to be sad, afraid or uncertain
It's okay to cry
It doesn't mean you are being negative
It doesn't mean you are weak
It takes great courage to be able to understand;
Accept and acknowledge what you feel!
Only then you can Face it, disempower it - and Let it go
Never suppress your feelings because you are too afraid of
what others will "Think" of you
You can Choose to make Positive Choices
And Change your "Response-ablity" to your Feelings
And Transform them into a Beautiful, Positive Power
Beyond anything you have ever imagined
You are stronger than you think
Let the Love and Peace inside you, awaken
Let "Begin" Heal you.
Love yourself and have Faith in your Journey
Life is waiting ... ♥

~ © Kiran Shaikh 2012 / Back Towards Light

Saturday, May 12, 2012

Beautiful Woman

Hello, These are virtues that do really make a woman beautiful!
Thanks for visiting,
Janet :)


Wednesday, May 9, 2012

Treatment For Anorexia Nervosa

Hello, I hope you are doing well today. This is an exciting study that may lead to a major breakthrough in finding a medicine that may finally treat Anorexia Nervosa. As of today there is no specific medicine out there to treat this disorder. Scientist are focusing in on what components of the drug Olanzapine work on the mice in the study and then developing a new medicine from those components to specifically treat Anorexia Nervosa. If you or anyone you know is suffering from this disorder, I would highly recommend following the developments of this study on Twitter or Facebook to see if this treatment becomes available.
Thanks for visiting,
Janet :)


Antipsychotic drug may be helpful treatment for Anorexia Nervosa

Mouse model of anorexia offers opportunity to study drugs effective for disorder

Low doses of a commonly used atypical antipsychotic drug improved survival in a mouse model of anorexia nervosa, University of Chicago researchers report this month. The result offers promise for a common and occasionally fatal eating disorder that currently lacks approved drugs for treatment.

Mice treated with small doses of the drug olanzapine were more likely to maintain their weight when given an exercise wheel and restricted food access, conditions that produce activity-based anorexia (ABA) in animals. The antidepressant fluoxetine, commonly prescribed off-label for anorexic patients, did not improve survival in the experiment.

"We found over and over again that olanzapine was effective in harsher conditions, less harsh conditions, adolescents, adults — it consistently worked," said the paper's first author Stephanie Klenotich, graduate student in the Committee on Neurobiology at the University of Chicago Biological Sciences.

The study, published in Neuropsychopharmacology, was the product of a rare collaboration between laboratory scientists and clinicians seeking new treatment options for anorexia nervosa. As many as one percent of American women will suffer from anorexia nervosa during their lifetime, but only one-third of those people will receive treatment.

Patients with anorexia are often prescribed off-label use of drugs designed for other psychiatric conditions, but few studies have tested the drugs effectiveness in animal models.

"Anorexia nervosa is the most deadly psychiatric disorder, and yet no approved pharmacological treatments exist," said Stephanie Dulawa, PhD, assistant professor of Psychiatry & Behavioral Neuroscience at the University of Chicago Medicine and senior author of the study. "One wonders why there isn't more basic science work being done to better understand the mechanisms and to identify novel pharmacological treatments."

One challenge is finding a medication that patients with anorexia nervosa will agree to take regularly, said co-author Daniel Le Grange, PhD, professor of Psychiatry & Behavioral Neuroscience and director of the Eating Disorders Clinic at the University of Chicago Medicine. Drugs that directly cause weight gain or carry strong sedative side effects are often rejected by patients.

"Patients are almost uniformly very skeptical and very reluctant to take any medication that could lower their resolve to refrain from eating," Le Grange said. "There are long-standing resistances, and I think researchers and clinicians have been very reluctant to embark on that course, since it's just littered with obstacles."

Both fluoxetine and olanzapine have been tried clinically to supplement interventions such as family-based treatment and cognitive-behavioral therapy. But their direct effect on anorexia nervosa behavior — in humans or animals — is lacking in sufficient data.

To test the effectiveness of these drugs in laboratory mice, Klenotich adapted the ABA protocol from previously published rat studies: Mice given 24-hour access to a running wheel but only six hours a day of food access become hyperactive, eat less and rapidly lose weight, with a 25 percent reduction from baseline considered to be the "drop-out" survival point.

In Klenotich's study, mice were pretreated with fluoxetine, olanzapine or saline before starting the ABA protocol, and treatment continued throughout the ABA period. Researchers then measured how many mice in each group reached the drop-out point for weight loss over 14 days of food restriction and exercise wheel access. Treatment with the antipsychotic olanzapine significantly increased survival over the control group, while fluoxetine treatment produced no significant effects on survival.

Importantly, a low dose of olanzapine did not decrease overall running activity in the mice, indicating that sedative effects of the drug were minimal. In future experiments, the researchers hope to use different drugs and genetic methods to determine exactly how olanzapine is effective against symptoms of anorexia nervosa, perhaps pointing toward a better drug without the negative image or side effects of an antipsychotic.

"We can dissect the effect of olanzapine and hopefully identify the mechanisms of action, and identify what receptor systems we want to target," Klenotich said. "Hopefully, we can develop a newer drug that we can aim towards the eating disorders clinic as an anorexic-specific drug that might be a little more acceptable to patients."

The study offers support for the clinical use of olanzapine, for which clinical trials are already under way to test in patients. Le Grange said the development of a pharmacological variant that more selectively treats anorexia nervosa could be a helpful way to avoid the "stigma" of taking an antipsychotic while giving clinicians an additional tool for helping patients.

"I think the clinical field is certainly very ready for something that is going to make a difference," Le Grange said. "I'm not saying there's a 'magic pill' for anorexia nervosa, but we have been lacking any pharmacological agent that clearly contributes to the recovery of our patients. Many parents and many clinicians are looking for that, because it would make our job so much easier if there was something that could turn symptoms around and speed up recovery."

Additionally, the study demonstrated the innovative experimental design and translational results that can come from a collaboration of laboratory and clinical experts.

"We don't talk to one another often enough in basic science and clinical science," Le Grange said. "More of that would be helpful for clinicians to understand the neurobiology of this disease. I'm very excited about the way this project is going, and I think it's going to be clinically very informative."

The paper, "Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice," was published online March 7 by Neuropsychopharmacology (doi: 10.1038/npp.2012.7). In addition to Klenotich, Dulawa and Le Grange, authors include Mariel Seiglie and Priya Dugad of the University of Chicago and Matthew S. McMurray and Jamie Roitman of the University of Illinois at Chicago. Funding for the research was provided by the National Institute of Mental Health.

For more news from the University of Chicago Medical Center, follow us on Twitter at @UChicagoMed, or visit our Facebook page

Sunday, May 6, 2012

Finest Moments

Hello, I hope your having a good weekend. Here's a little inspiration for your Sunday.
Thanks for visiting,
Janet :)


Thursday, May 3, 2012

Junior Seau

Hello, I was shocked yesterday after hearing of Junior Seau's suicide. He was a Professional Football player who ended his Career with my favorite football team, The Patriots. His 20 yr Career began with the San Diego Chargers. I couldn't understand at first why this player who seemed to have such a great life would want to commit suicide. Then as I listened to the news and heard many people speak about what they believed he may have suffered from, the condition called CTE, I decided to learn more about it. I learned the connection between CTE and suicide is that researchers have found that the inflammation in the brain caused by CTE, is the major reason that depression occurs which can often lead to suicide. Sadly, Athletes, who have developed high pain tolerance during their careers, may not not even be fully aware of the extent of the brain injuries. This condition is being studied more intensely due to the rise in suicides in professional players. There is no definite treatment for this condition from what I have read. The best that any player can do right now is to take the time to treat concussions and be aware of the signs. If you have a child or someone you know who plays sports, this is a condition that you should be aware of. Hopefully in time, this condition, CTE, having more research, will lead to better treatments in order to prevent the devastating effect of suicide on those who suffer from it.
Thanks for visiting,

Seau will be remembered as one of the greatest players in NFL history at any position, a 6-foot-3, 248-pound wrecking ball who made the Pro Bowl 12 years in a row and was voted All-Pro 10 times. He often veered from the script on the field, and that only made him more effective

What is CTE?
Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease of the brain found in athletes (and others) with a history of repetitive brain trauma, including symptomatic concussions as well as asymptomatic subconcussive hits to the head. CTE has been known to affect boxers since the 1920s. However, recent reports have been published of neuropathologically confirmed CTE in retired professional football players and other athletes who have a history of repetitive brain trauma. This trauma triggers progressive degeneration of the brain tissue, including the build-up of an abnormal protein called tau. These changes in the brain can begin months, years, or even decades after the last brain trauma or end of active athletic involvement.

By 2009, only 49 cases of CTE had ever been studied pathologically and published in medical literature, so the disease is still poorly understood

Deterioration in attention, concentration, memory
Lack of insight
Poor judgment
Overt dementia
Slowed muscular movements
Staggered gait
Impeded speech

There are three stages of progression in CTE:
The first stage is characterized by its disturbances and psychotic symptoms.
In the second stage of the disease the patient may suffer erratic behavior, memory loss, and the initial symptoms of Parkinsons disease.
The final stage is full blown dementia as well as symptoms related to Parkinsons disease.

Treatment for CTE
Modern traditional medicine physicians are exploring the use of electric current in the brain. For example, there is an electrical treatment called “deep brain stimulation” which is currently being used to treat depression and various other illnesses such as epilepsy